Clinical features |
Drug, route of administration (choose one) |
Dosage |
Treatment duration (days) |
Tick bite where rate of tick infections is <10% and/or tick was on for <24 h |
Monitoringb |
|
|
– Erythema migrans – Borrelial lymphocytoma – Cranial neuritisc (palsy) |
Doxycycline,b PO |
100 mg bid or 200 mg once daily |
14-21 |
Amoxicillin, PO |
500-1000 mg tid (children 50 mg/kg/d) |
14-21 | |
Cefuroxime axetil, PO |
500 mg bid (children 30 mg/kg/d) |
14-21 | |
Arthritis (first episode) |
Doxycycline, PO |
100 mg bid or 200 mg once daily |
14-28 |
Amoxicillin, PO |
500-1000 mg tid (children 50 mg/kg/d) |
14-28 | |
Cefuroxime axetil, PO |
500 mg bid (children 30 mg/kg/d) |
14-28 | |
– Neuroborreliosis – Arthritis (relapse) – Carditis |
Ceftriaxone, IV |
2000 mg once daily (children 50-75 mg/kg/d) |
14-28 |
Cefotaxime, IV |
2000 mg tid (children 150-200 mg/kg/d in 3-4 divided doses) |
14-28 | |
Acrodermatitis chronica atrophicans |
Doxycycline, PO |
100 mg bid or 200 mg once daily |
14-28 |
Amoxicillin, PO |
500-1000 mg tid |
14-28 | |
Ceftriaxone, IV |
2000 mg once daily |
14-28 | |
Cefotaxime, IV |
2000 mg tid |
14-28 | |
a Based on guidelines from the Infectious Diseases Society of America and the Polish Society of Epidemiology and Infectious Diseases (2020). b Tetracyclines are contraindicated in pregnancy and for children aged <8 years. Macrolides are considered third-line therapy and should be reserved for patients with contraindications to both beta-lactams and doxycycline. c Evaluate for signs and symptoms of meningitis. | |||
bid, 2 times a day; IV, intravenous; PO, oral; tid, 3 times a day. |